These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35103734)

  • 1. Neuroprotection of chicoric acid in a mouse model of Parkinson's disease involves gut microbiota and TLR4 signaling pathway.
    Wang N; Feng BN; Hu B; Cheng YL; Guo YH; Qian H
    Food Funct; 2022 Feb; 13(4):2019-2032. PubMed ID: 35103734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chicoric Acid Prevents Neuroinflammation and Neurodegeneration in a Mouse Parkinson's Disease Model: Immune Response and Transcriptome Profile of the Spleen and Colon.
    Wang N; Li R; Feng B; Cheng Y; Guo Y; Qian H
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Effects of Sodium Butyrate by Restoring Gut Microbiota and Inhibiting TLR4 Signaling in Mice with MPTP-Induced Parkinson's Disease.
    Guo TT; Zhang Z; Sun Y; Zhu RY; Wang FX; Ma LJ; Jiang L; Liu HD
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin Pretreatment on MPTP-Induced Parkinson's Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and Gut.
    Cui C; Hong H; Shi Y; Zhou Y; Qiao CM; Zhao WJ; Zhao LP; Wu J; Quan W; Niu GY; Wu YB; Li CS; Cheng L; Hong Y; Shen YQ
    J Neuroimmune Pharmacol; 2023 Jun; 18(1-2):72-89. PubMed ID: 35091889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chicoric acid supplementation prevents systemic inflammation-induced memory impairment and amyloidogenesis
    Liu Q; Chen Y; Shen C; Xiao Y; Wang Y; Liu Z; Liu X
    FASEB J; 2017 Apr; 31(4):1494-1507. PubMed ID: 28003341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson's Disease: Implications for Gut Microbiota and PGC-1α.
    Dong Y; Qi Y; Chen J; Han S; Su W; Ma X; Yu Y; Wang Y
    Mol Neurobiol; 2024 Oct; 61(10):7534-7548. PubMed ID: 38409641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
    Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
    Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis.
    Zhao Z; Ning J; Bao XQ; Shang M; Ma J; Li G; Zhang D
    Microbiome; 2021 Nov; 9(1):226. PubMed ID: 34784980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resveratrol protects dopaminergic neurons in a mouse model of Parkinson's disease by regulating the gut-brain axis
    Gui J; Sun X; Wen S; Liu X; Qin B; Sang M
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Feb; 44(2):270-279. PubMed ID: 38501412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
    Cui C; Han Y; Li H; Yu H; Zhang B; Li G
    Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.
    Aktas B; Aslim B; Ozdemir DA
    Sci Rep; 2024 Jul; 14(1):15460. PubMed ID: 38965287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective Effect of Ceftriaxone on MPTP-Induced Parkinson's Disease Mouse Model by Regulating Inflammation and Intestinal Microbiota.
    Zhou X; Lu J; Wei K; Wei J; Tian P; Yue M; Wang Y; Hong D; Li F; Wang B; Chen T; Fang X
    Oxid Med Cell Longev; 2021; 2021():9424582. PubMed ID: 34938384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rubusoside mitigates neuroinflammation and cellular apoptosis in Parkinson's disease, and alters gut microbiota and metabolite composition.
    Meng T; Zhang Y; Huang J; Pandey V; Fu S; Ma S
    Phytomedicine; 2024 Feb; 124():155309. PubMed ID: 38237261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson's disease.
    Liao JF; Cheng YF; You ST; Kuo WC; Huang CW; Chiou JJ; Hsu CC; Hsieh-Li HM; Wang S; Tsai YC
    Brain Behav Immun; 2020 Nov; 90():26-46. PubMed ID: 32739365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR2 deficiency is beneficial at the late phase in MPTP-induced Parkinson' disease mice.
    He Y; Zhao J; Dong H; Zhang X; Duan Y; Ma Y; Yu M; Fei J; Huang F
    Life Sci; 2023 Nov; 333():122171. PubMed ID: 37827233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective role of microbiota in the prevention of MPTP/P-induced Parkinson's disease by resveratrol.
    Tao J; An Y; Xu L; Wang Y; Wang C; Li P; Li M; Yan D; Wang M; Zhong G; Wu M
    Food Funct; 2023 May; 14(10):4647-4661. PubMed ID: 37102320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson's disease via gut microbiota-GLP-1 pathway.
    Sun J; Li H; Jin Y; Yu J; Mao S; Su KP; Ling Z; Liu J
    Brain Behav Immun; 2021 Jan; 91():703-715. PubMed ID: 33148438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allantoin ameliorates dopaminergic neuronal damage in MPTP-induced Parkinson's disease mice
    Yang S; Sun X; Liu D; Zhang Y; Gao X; He J; Cui M; Fu S; He D
    Food Funct; 2024 Sep; 15(18):9390-9408. PubMed ID: 39189380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound Dihuang Granule Changes Gut Microbiota of MPTP-Induced Parkinson's Disease Mice via Inhibiting TLR4/NF-κB Signaling.
    He ZQ; Huan PF; Wang L; He JC
    Neurochem Res; 2023 Dec; 48(12):3610-3624. PubMed ID: 37561259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of the Preparation Process of Glucuronomannan Oligosaccharides and Their Effects on the Gut Microbiota in MPTP-Induced PD Model Mice.
    Wang B; Geng L; Wang J; Wei Y; Yan C; Wu N; Yue Y; Zhang Q
    Mar Drugs; 2024 Apr; 22(5):. PubMed ID: 38786584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.